StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Renalytix's enterprise value was $588.96M on Oct 19, 2026, against $22.50B a year earlier. Over the last 5 years it ranged from $216.45M to $834.72B, with a median of $30.29B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$588.96M-1.8%
2025Dec 31, 2025$599.74M-97.2%
2024Dec 31, 2024$21.78B-4.7%
2023Dec 29, 2023$22.85B-73.9%
2022Dec 30, 2022$87.50B-87.8%
2021Dec 31, 2021$717.40B+20.7%
2020Dec 31, 2020$594.15B–

More Renalytix figures

See a number that looks wrong?